These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24308946)

  • 1. Analysis of the duration of migraine prophylaxis.
    Silva-Néto RP; Almeida KJ; Bernardino SN
    J Neurol Sci; 2014 Feb; 337(1-2):38-41. PubMed ID: 24308946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open pilot study assessing the benefits of quetiapine for the prevention of migraine refractory to the combination of atenolol, nortriptyline, and flunarizine.
    Krymchantowski AV; Jevoux C; Moreira PF
    Pain Med; 2010 Jan; 11(1):48-52. PubMed ID: 20002594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flunarizine for prophylactic treatment of childhood migraine.
    Visudtibhan A; Lusawat A; Chiemchanya S; Visudhiphan P
    J Med Assoc Thai; 2004 Dec; 87(12):1466-70. PubMed ID: 15822542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis.
    Luo N; Di W; Zhang A; Wang Y; Ding M; Qi W; Zhu Y; Massing MW; Fang Y
    Pain Med; 2012 Jan; 13(1):80-6. PubMed ID: 22233396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.
    Cady R; Nett R; Dexter K; Freitag F; Beach ME; Manley HR
    Headache; 2014 Jan; 54(1):80-93. PubMed ID: 24020994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flunarizine in migraine prophylaxis: predictive factors for a positive response.
    Lucetti C; Nuti A; Pavese N; Gambaccini G; Rossi G; Bonuccelli U
    Cephalalgia; 1998; 18(6):349-52. PubMed ID: 9731940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine for the prevention of migraine refractory to the combination of atenolol + nortriptyline + flunarizine: an open pilot study.
    Krymchantowski AV; Jevoux C
    Arq Neuropsiquiatr; 2008 Sep; 66(3B):615-8. PubMed ID: 18949250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flunarizine in long-term migraine prophylaxis: clinical evidence.
    Colucci D'Amato C; Colucci D'Amato A; Alfano V; Giordano E; Marmo E
    J Med; 1990; 21(3-4):201-7. PubMed ID: 2398321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of flunarizine in the prophylaxis of migraine: a meta-analytical review of the literature].
    Reveiz-Herault L; Cardona AF; Ospina EG; Carrillo P
    Rev Neurol; 2003 May 16-31; 36(10):907-12. PubMed ID: 12766861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zonisamide for migraine prophylaxis in refractory patients.
    Ashkenazi A; Benlifer A; Korenblit J; Silberstein SD
    Cephalalgia; 2006 Oct; 26(10):1199-202. PubMed ID: 16961786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
    Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J
    Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perimenstrual eletriptan prevents menstrual migraine: an open-label study.
    Marcus DA; Bernstein CD; Sullivan EA; Rudy TE
    Headache; 2010 Apr; 50(4):551-62. PubMed ID: 20236337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of migraine is a predictor for response to botulinum toxin type A.
    Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
    Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of cinnarizine in the prophylaxis of migraine headaches in children: an open, randomized comparative trial with propranolol.
    Togha M; Malamiri RA; Rashidi-Ranjbar N; Asa S; Mahvelati F; Ashrafi MR
    Acta Neurol Belg; 2012 Mar; 112(1):51-5. PubMed ID: 22427290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.
    Krymchantowski AV; Jevoux CC
    Headache; 2011 Apr; 51(4):554-8. PubMed ID: 21457240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain characteristics of the acute migraine attack.
    Kelman L
    Headache; 2006 Jun; 46(6):942-53. PubMed ID: 16732840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
    Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.